article thumbnail

Scientists engineer safe, virus-resistant E coli for research

Drug Discovery World

In a step forward for genetic engineering and synthetic biology, US researchers have modified E coli bacteria to be immune to infection by all natural viruses tested so far. The HMS researchers added new, ‘trickster’ tRNAs, which add leucine instead of serine.

article thumbnail

Vitamin D Overdose Among Emerging Risks Identified by EFSA

XTalks

Specialists emphasized the need for more comprehensive research to solidify the evidence concerning its possible toxicity. Nations were prompted to gather data regarding incidence, human prevalence and risk exposure channels to more comprehensively define the threat.

Bacterium 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available. Blood and blood components. Allergenics. Somatic cells. Gene and cellular therapies. Recombinant therapeutic proteins. Growth factors.

article thumbnail

101 Toxic Food Ingredients – New Conversion Breakthrough

The Pharma Data

every day are contaminated with at LEAST ONE TOXIC ingredient. I know it may sound a bit like a tongue twister, but with over 14 years of experience in the health and fitness industry, I have spent THOUSANDS of hours relentlessly researching food ingredients and the effects they have on our bodies. When lab rats were given G.M.O.

article thumbnail

Cell culture Q&A: Solving biomanufacturing challenges with Recombinant Insulin supplementation

Pharmaceutical Technology

It is no exaggeration to say that the world changed in the early 80s when insulin was expressed synthetically in microorganisms for the first time. This breakthrough led to a recombinant (biosynthetic) and thereby safer therapy for diabetes than the animal-sourced insulin which had been used since 1922.

Insulin 130